The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination-Reference-Cited by-同舟云学术

The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination

Published:2007-10 Issue:4 Volume:197 Page:337-339
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Monk Bradley J.,Herzog Thomas J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference11 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost;Yang;Int J Cancer,2004

3. Cancer Facts and Figures 2007,2007

4. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature;Insinga;Pharmacoeconomics,2005

5. Vaccines against human papillomavirus and cervical cancer: promises and challenges;Mahdavi;Oncologist,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer;The Tohoku Journal of Experimental Medicine;2021

2. Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer;Journal of Turkish Society of Obstetric and Gynecology;2020-07-29

3. Effects and possible mechanism of a picosecond pulsed electric field on angiogenesis in cervical cancer in�vitro;Oncology Letters;2018-11-30

4. The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer;EUR J GYNAECOL ONCOL;2017

5. Epigallocatechin-3-gallate shows anti-proliferative activity in HeLa cells targeting tubulin-microtubule equilibrium;Chemico-Biological Interactions;2015-12